Navigation Links
Global Blood Screening (Nucleic Acid Amplification Test, ELISA, Rapid Test, Chemiluminescence Immunoassay, Next Generation Sequencing, Western Blotting) Market 2015-2019
Date:4/1/2015

DUBLIN, Mar. 30, 2015 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/8dzk58/blood_screening) has announced the addition of the "Blood Screening Market by Technology (Nucleic Acid Amplification Test, ELISA, Rapid Test, Chemiluminescence Immunoassay, Next Generation Sequencing, Western Blotting), Product (Instrument, Reagent) & End User (Blood Bank, Hospital) - Forecasts to 2019 " report to their offering.

The blood screening market is expected to reach $2.55 billion by 2019 from $1.5 billion in 2014, growing at a CAGR of 10.4% from 2014 to 2019. The global market is segmented on the basis of products and services, technologies, end users, and regions.

The blood screening market is a growing field that has witnessed a number of technological advancements since its inception, such as a shift from first-generation ELISA to advanced NAT technologies. This market is driven by several factors including increasing number of blood donations and blood donors, rising awareness regarding the safety of donated blood, increasing patient affordability, increasing adoption of NAT, and rising demand of donated blood. However, factors such as high capital expenditure and operating cost of NAT and stringent regulatory approval processes are likely to hinder the growth of this market. The blood screening market in Asia is likely to provide an array of opportunities owing to the growing demand for donated blood, increasing disposable income (leading to adoption of NAT ), and increased focus of key players in the Asian region.

On the basis of products and services, the global market is segmented into instruments (hardware), reagents, and software and services. The blood screening instruments market is further segmented into rental purchase and outright purchase; while the blood screening reagents market segment is classified into ELISA reagents, NAT reagents, and other reagents.

On the basis of technologies, the global global market is segmented into nucleic acid tests (NAT), enzyme-linked immunosorbent assays (ELISA), enzyme immunoassays (EIAs) and chemiluminescent immunoassays (CLIAs), next-generation sequencing (NGS), and Western blot assays. The blood screening NAT market is further segmented into transcription mediated amplification (TMA) and real-time PCR. The blood screening market for ELISA testing is further categorized into card methodology, first-generation, second-generation, third-generation, and fourth-generation ELISA.

Based on end users, the blood screening market is segmented into blood banks and hospitals.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Trends

7 Blood Screening Market, By Technology

8 Blood Screening Market, By Products and Services

9 Blood Screening Market, By End User

10 Blood Screening Market, By Region

11 Competitive Landscape

12 Company Profiles

- Abbott Laboratories
- Beckman Coulter (Subsidiary of Danaher Corporation)
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Biomérieux
- Grifols
- Ortho-Clinical Diagnostics, Inc.
- Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd)
- Siemens Healthcare (Subsidiary of Siemens AG)
- Thermo Fisher Scientific, Inc.

For more information visit http://www.researchandmarkets.com/research/8dzk58/blood_screening

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net


'/>"/>
SOURCE Research and Markets
Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. Forensic Technologies and Services - Global Strategic Business Report 2015-2020: Rise in Terrorist Bombings Sharpens the Business Case for Explosives Forensics
2. Social Media Role in Global Insurance Industry Examined by Timetric in New Market Research Report Published at MarketPublishers.com
3. Global Astaxanthin Market to Reach Value of USD 1.1 billion by 2020, Expects Industry Experts in New Report Available at MarketPublishers.com
4. International Organization Expands its Global Reach to Warsaw, Poland
5. Global HER-2 Positive Breast Cancer Market 2015-2019 - Key Players are Celgene, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis & Sanofi
6. Portages Biohaven enters into exclusive formulation agreement and global license with Catalent for lead product
7. Bynder and HubCast Forge Global Partnership for Transformative “Concept to Delivery” Solution
8. Global Engineered TCR and CAR Immunotherapeutics Analysis Report 2015
9. Greater Omaha Economic Development Partnership is VIP Sponsor for ITRA Global Spring Conference
10. Global Stem Cells Group to Hold Practical Adipose-Derived Stem Cell Harvesting, Isolation and Re-integration Training Course in Santa Cruz, Bolivia
11. Global Animal Genetics Market Worth Around $4 Billion by 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2019)... YORK (PRWEB) , ... May 22, 2019 , ... ... has closed a $8 million Series A funding round co-led by Astanor Ventures ... Empire State Development Fund and iSelect Fund . The company has ...
(Date:5/15/2019)... ... May 16, 2019 , ... ... As a result, food and beverage products rely on these ingredients to create ... natural sounding label declarations. This paradigm shift triggers food formulators to seek out ...
(Date:5/8/2019)... ... ... Standing at 16.2 hands, Atlas is on the large side for a Quarter Horse. ... among other activities. When loping around a corner in late 2017, Atlas tripped and ... to only being able to walk. Fortunately Atlas’ owner, Kelly, sought the opinion of ...
(Date:5/4/2019)... ... May 03, 2019 , ... Diopsys ... Diopsys® ffERG/Photopic Negative Response vision test, a new full field electroretinography ... is estimated that 6.3 million Americans will have glaucoma, with black Americans having ...
Breaking Biology Technology:
(Date:6/11/2019)... ... June 12, 2019 , ... With a rapidly growing customer ... the Geneious Biologics platform as a premium hub for bioinformatics and computer programming ... “The Geneious team has done an excellent job accommodating our specific data, resulting ...
(Date:6/6/2019)... ... June 05, 2019 , ... ... and solutions in the global health and medical technology market, announced that it ... Healthcare Navigation / Robotics Solution” award in the 2019 MedTech Breakthrough Awards program. ...
(Date:6/6/2019)... ... June 05, 2019 , ... ... exclusive financial advisor to Pathologists Bio-Medical Laboratories (PBM) on its recent acquisition by ... pathology platform that provides services to more than one dozen hospitals and surgery ...
Breaking Biology News(10 mins):